Devin Welty

5.8k total citations · 3 hit papers
39 papers, 4.2k citations indexed

About

Devin Welty is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Devin Welty has authored 39 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Pharmacology. Recurrent topics in Devin Welty's work include Neuroscience and Neuropharmacology Research (9 papers), Retinal Diseases and Treatments (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Devin Welty is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Retinal Diseases and Treatments (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Devin Welty collaborates with scholars based in United States, Ireland and Netherlands. Devin Welty's co-authors include Jeffrey D. Rothstein, Ralph W. Kuncl, Yanfeng Wang, Margaret Dykes‐Hoberg, Carlos A. Pardo, Matthias A. Hediger, Lynn A. Bristol, Jin Li, Yoshikatsu Kanai and Charles P. Taylor and has published in prestigious journals such as Neuron, Journal of Neuroscience and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Devin Welty

38 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

1996 2.1k citations Jeffrey D. Rothstein, Margaret Dykes‐Hoberg et al. Neuron profile →
A summary of mechanistic hypotheses of gabapentin pharmacology

1998 596 citations Charles P. Taylor, N S Gee et al. Epilepsy Research profile →
Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant

2010 456 citations Andrew Acheampong, Scott M. Whitcup et al. Investigative Ophthalmology & Visual Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Devin Welty United States	17	2.1k	1.3k	716	683	594	39	4.2k
Elena Alberdi Spain	38	1.4k 0.7×	1.6k 1.3×	228 0.3×	1.0k 1.5×	1.3k 2.3×	71	4.6k
Shigeru Okuyama Japan	37	3.2k 1.5×	2.9k 2.3×	147 0.2×	722 1.1×	530 0.9×	148	6.4k
Annakaisa Haapasalo Finland	36	1.4k 0.7×	2.1k 1.6×	171 0.2×	2.0k 2.9×	862 1.5×	109	5.3k
R. Gill United Kingdom	29	1.8k 0.9×	1.5k 1.2×	131 0.2×	394 0.6×	591 1.0×	35	3.2k
Brant D. Watson United States	33	1.1k 0.5×	990 0.8×	127 0.2×	605 0.9×	1.0k 1.8×	65	3.9k
Domenico E. Pellegrini‐Giampietro Italy	40	3.3k 1.6×	2.5k 2.0×	78 0.1×	746 1.1×	996 1.7×	125	5.9k
Carla L. Busceti Italy	42	2.0k 1.0×	1.7k 1.3×	76 0.1×	881 1.3×	615 1.0×	141	4.6k
Reidun Torp Norway	30	1.9k 0.9×	1.8k 1.4×	78 0.1×	1.4k 2.0×	745 1.3×	56	4.0k
Ann Benz United States	27	1.7k 0.8×	1.4k 1.1×	117 0.2×	406 0.6×	275 0.5×	62	2.6k
Joann Labruyere United States	28	2.9k 1.4×	1.7k 1.4×	67 0.1×	431 0.6×	441 0.7×	33	5.2k

Countries citing papers authored by Devin Welty

Since Specialization

Citations

This map shows the geographic impact of Devin Welty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin Welty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin Welty more than expected).

Fields of papers citing papers by Devin Welty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devin Welty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin Welty. The network helps show where Devin Welty may publish in the future.

Co-authorship network of co-authors of Devin Welty

This figure shows the co-authorship network connecting the top 25 collaborators of Devin Welty. A scholar is included among the top collaborators of Devin Welty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devin Welty. Devin Welty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Welty, Devin, et al.. (2021). Elucidation of Metabolic and Disposition Pathways for Maribavir in Nonhuman Primates through Mass Balance and Semi–Physiologically Based Modeling Approaches. Drug Metabolism and Disposition. 49(11). 1025–1037. 7 indexed citations

Welty, Devin, et al.. (2019). In vitro metabolic and transporter profiling for maribavir (SHP620). Drug Metabolism and Pharmacokinetics. 34(1). S61–S61. 1 indexed citations

Spencer, Elizabeth A., et al.. (2017). Ocular distribution and pharmacokinetics of lifitegrast following repeat topical ocular dose administration to pigmented rabbits. Investigative Ophthalmology & Visual Science. 58(8). 449–449. 1 indexed citations

Spencer, Elizabeth A., et al.. (2017). Ocular Distribution and Pharmacokinetics of Lifitegrast in Pigmented Rabbits and Mass Balance in Beagle Dogs. Journal of Ocular Pharmacology and Therapeutics. 34(1-2). 224–232. 10 indexed citations

Li, Aiqun, Karen Rowland Yeo, Devin Welty, & Haojing Rong. (2017). Development of Guanfacine Extended-Release Dosing Strategies in Children and Adolescents with ADHD Using a Physiologically Based Pharmacokinetic Model to Predict Drug–Drug Interactions with Moderate CYP3A4 Inhibitors or Inducers. Pediatric Drugs. 20(2). 181–194. 17 indexed citations

Goethem, Nick P. van, Jos Prickaerts, Devin Welty, Dorothy G. Flood, & Gerhard Koenig. (2015). Continuous infusion of the α7 nicotinic acetylcholine receptor agonist EVP-6124 produces no signs of tolerance at memory-enhancing doses in rats. Behavioural Pharmacology. 26(4). 403–406. 10 indexed citations

Tang, Cuyue, Ting Chen, Tao Yi, et al.. (2014). Neuropharmacokinetics of two investigational compounds in rats: Divergent temporal profiles in the brain and cerebrospinal fluid. Biochemical Pharmacology. 91(4). 543–551. 11 indexed citations

Tang, Cuyue & Devin Welty. (2013). A dynamic view to the modulation of phosphorylation and O-GlcNAcylation by inhibition of O-GlcNAcase. Computational Biology and Chemistry. 45. 9–16. 1 indexed citations

Ni, Jinsong, et al.. (2008). Microdosing Assessment to Evaluate Pharmacokinetics and Drug Metabolism in Rats Using Liquid Chromatography-Tandem Mass Spectrometry. Pharmaceutical Research. 25(7). 1572–1582. 29 indexed citations

10.

Dong, Jennifer, Darius Babusis, Devin Welty, et al.. (2004). Effects of the Preservative Purite ^® on the Bioavailability of Brimonidine in the Aqueous Humor of Rabbits. Journal of Ocular Pharmacology and Therapeutics. 20(4). 285–292. 32 indexed citations

11.

Shen, Jie, et al.. (2003). Evaluation of an Immortalized Retinal Endothelial Cell Line as an In Vitro Model for Drug Transport Studies Across the Blood-Retinal Barrier. Pharmaceutical Research. 20(9). 1357–1363. 33 indexed citations

12.

Woodward, David F., Achim H.‐P. Krauss, Yuanbo Liang, et al.. (2003). Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024). Journal of Pharmacology and Experimental Therapeutics. 305(2). 772–785. 115 indexed citations

13.

Acheampong, Andrew, et al.. (2002). Formulation Effects on Ocular Absorption of Brimonidine in Rabbit Eyes. Journal of Ocular Pharmacology and Therapeutics. 18(4). 325–337. 36 indexed citations

14.

Taylor, Charles P., N S Gee, Ti‐Zhi Su, et al.. (1998). A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Research. 29(3). 233–249. 596 indexed citations breakdown →

15.

Rothstein, Jeffrey D., Margaret Dykes‐Hoberg, Carlos A. Pardo, et al.. (1996). Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate. Neuron. 16(3). 675–686. 2092 indexed citations breakdown →

16.

Robertson, Donald G., Brian R. Krause, Devin Welty, et al.. (1995). Hepatic microsomal induction profile of carbamic acid [[2,6-bis(1-methylethyl)phenoxy] sulfonyl]-2,6-bis(1-methylethyl) phenyl ester, monosodium salt (PD138142-15), a novel lipid regulating agent. Biochemical Pharmacology. 49(6). 799–808. 5 indexed citations

17.

Goldlust, Arie, Ti‐Zhi Su, Devin Welty, Charles P. Taylor, & Dale L. Oxender. (1995). Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Research. 22(1). 1–11. 128 indexed citations

18.

Welty, Devin, Gerald P. Schielke, Mark G. Vartanian, & Charles P. Taylor. (1993). Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate. Epilepsy Research. 16(3). 175–181. 107 indexed citations

19.

Soine, William H., et al.. (1990). LC determination of the diastereomers of 1-(β-d-glucopyranosyl) phenobarbital in human urine. Journal of Pharmaceutical and Biomedical Analysis. 8(4). 365–372. 8 indexed citations

20.

Nestler, John E., Keith Usiskin, Cornelius Barlascini, et al.. (1989). Suppression of Serum Dehydroepiandrosterone Sulfate Levels by Insulin: An Evaluation of Possible Mechanisms *. The Journal of Clinical Endocrinology & Metabolism. 69(5). 1040–1046. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact